Hythiam to Announce Fourth Quarter and Fiscal 2008 Year-End Results on Tuesday, March 31st

LOS ANGELES--(Business Wire)--
Hythiam, Inc. (NASDAQ:HYTM) announced today that it is scheduled to report
financial results for its fourth quarter and fiscal year ended December 31, 2008
on Tuesday, March 31, 2009, after the market closes.

Hythiam will hold a conference call at 1:30 p.m. PT (4:30 p.m. ET) on that day.
Interested parties are invited to listen to the call live over the Internet at
http://www.hythiam.com or http://www.vcall.com. The call is also available by
dialing (877) 407-8031, or for international callers (201) 689-8031. A replay of
the webcast will be available after the call on http://www.hythiam.com or
http://www.vcall.com. A telephonic replay will also be available until 11:59
p.m. ET on April 30, 2009, by dialing (877) 660-6853 or (201) 612-7415 for
international callers, and entering account number 286 and the conference code
318438.

About Hythiam®

Hythiam, Inc. provides, through its CatasysTM offering, behavioral health
management services to health plans, employers and unions through a network of
licensed and company managed healthcare providers. The Catasys substance
dependence program is built around medical and psychosocial interventions,
including the patented PROMETA® Treatment Program for alcoholism and stimulant
dependence. The PROMETA Treatment Program, which integrates behavioral,
nutritional, and medical components, is also available on a private-pay basis
through licensed treatment providers and company managed treatment centers.
Hythiam does not practice medicine or manufacture, distribute, or sell any
medications and has no relationship with any manufacturers or distributors of
medications used in the PROMETA Treatment Program. For further information,
please visit www.hythiam.com.

Forward-Looking Statements

Except for statements of historical fact, the matters discussed in this press
release are forward looking and made pursuant to the Safe Harbor provisions of
the Private Securities Litigation Reform Act of 1995. These forward-looking
statements reflect numerous assumptions and involve a variety of risks and
uncertainties, many of which are beyond the company's control that may cause
actual results to differ materially from stated expectations. These risk factors
include, among others, limited operating history and lack of statistically
significant formal research studies, the risk that treatment protocols might not
be effective, difficulty in developing, exploiting and protecting proprietary
technologies, intense competition and substantial regulation in the healthcare
industry; and additional risks factors as discussed in the reports filed by the
company with the Securities and Exchange Commission, which are available on its
website at http://www.sec.gov.

Hythiam, Inc.
Investor Relations:
Stacey Stockhaus
310-444-4333
sstockhaus@hythiam.com

Copyright Business Wire 2009